Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01. [electronic resource]
Producer: 20160502Description: 181-7 p. digitalISSN:- 1879-0852
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- mortality
- Chemoradiotherapy -- adverse effects
- Cisplatin -- therapeutic use
- Consolidation Chemotherapy -- adverse effects
- Disease-Free Survival
- Female
- Humans
- Induction Chemotherapy -- adverse effects
- Lung Neoplasms -- mortality
- Male
- Middle Aged
- Neoplasm Staging
- Paclitaxel -- therapeutic use
- Radiotherapy Dosage
- Risk Factors
- Survival Analysis
- Time Factors
- Treatment Outcome
- Vinblastine -- analogs & derivatives
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.